WVE-007 is a novel, long-acting GalNAc-siRNA targeting INHBE mRNA - a genetically validated target that provides a new approach for healthy, sustainable weight loss (fat loss with muscle preservation) ...
The FDA has granted orphan drug designation (ODD) and RPDD to Arbor Biotechnologies' ABO-101, to treat primary hyperoxaluria ...
WVE-007 is a novel, long-acting GalNAc-siRNA targeting INHBE mRNA – a genetically validated target that provides a new approach for healthy, ...
Researchers uncover key mechanisms in gene regulation that may lead to better design of RNA-based medicines.
AZoLifeSciences on MSN15h
Study Uncovers Mechanisms for RNA Transport and Heritable Gene RegulationRNA-based medicines are one of the most promising ways to fight human disease, as demonstrated by the recent successes of RNA ...
Superintendent Critchfield proposes changing Idaho's school funding formula to distribute money based on individual student ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback